3NUMATA K,TANAKA K,KIBA T,ET AL.Using contrast enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocelluar carcinoma[J].AJR,2001,176(5):1199 -1205.
5MILLER E,LERMAN H,GUTMAN M,et al.The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer[J].Invest Radiol,2004,39(1):8-12.
6SIRINI S,DE COBELI F,LIVRAGHI T,et al.Small hepatocelluar carcinoma treated with percutaneous ethanol injection:unenhanced and gadolium-enhanced MRI imaging follow-up[J].Radiology,1994,192(3):407-412.
7PALMA L D.Diagnostic imaging and interventional therapy of hepatocelluar carcinoma[J].Br J Radiol,1998,71(848):808-818.
8KOSTAKOGLU L,AGRESS H Jr,GOLDSMITH S J.Clinical role of FDG PET in evaluation of cancer patients[J].Radiographics,2003,23(2):315-340.
9KOSTAKOGLU L,GOLDSMITH S J.18F-FDG PET evaluation of the response to therapy for lymphoma and for breast,lung,and colorectal carcinoma[J].J Nucl Med,2003,44(2):244-239.
10CZERNIN J.Clinical applications of FDG PET on oncology[J].Acta Med Austriaca,2002,29(5):162-170.
